The Bronchoprotective Effects of Dual Pharmacology, Muscarinic Receptor Antagonist and β(2) Adrenergic Receptor Agonist Navafenterol in Human Small Airways

Bronchodilators and anti-inflammatory agents are the mainstream treatments in chronic obstructive and pulmonary disease (COPD) and asthma. The combination of β(2) adrenergic receptor (β(2)AR) agonists and muscarinic antagonists shows superior bronchoprotective effects compared to these agents indivi...

Descripción completa

Detalles Bibliográficos
Autores principales: Jude, Joseph Antony, Dainty, Ian, Karmacharya, Nikhil, Jester, William, Panettieri, Reynold
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856842/
https://www.ncbi.nlm.nih.gov/pubmed/36672178
http://dx.doi.org/10.3390/cells12020240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856842/
https://www.ncbi.nlm.nih.gov/pubmed/36672178
http://dx.doi.org/10.3390/cells12020240

Ejemplares similares